IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc.verified

IDYA

Price:

$25.575

Market Cap:

$2.21B

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patie...[Read more]

Industry

Biotechnology

IPO Date

2019-05-23

Stock Exchange

NASDAQ

Ticker

IDYA

The Enterprise Value as of December 2024 (TTM) for IDEAYA Biosciences, Inc. (IDYA) is 1.83B

According to IDEAYA Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.83B. This represents a change of -28.44% compared to the average of 2.56B of the last 4 quarters.

IDEAYA Biosciences, Inc. (IDYA) Historical Enterprise Value (quarterly & annually)

How has IDYA Enterprise Value performed in the past?

The mean historical Enterprise Value of IDEAYA Biosciences, Inc. over the last ten years is 575.36M. The current 1.83B Enterprise Value has changed 31.69% with respect to the historical average. Over the past ten years (40 quarters), IDYA's Enterprise Value was at its highest in in the March 2024 quarter at 3.09B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

575.36M

Median

280.79M

Minimum

124.46M

Maximum

1.89B

IDEAYA Biosciences, Inc. (IDYA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IDEAYA Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 175.10%

Maximum Annual Enterprise Value = 1.89B

Minimum Annual Increase = -11.34%

Minimum Annual Enterprise Value = 124.46M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.89B175.10%
2022687.90M-7.85%
2021746.50M165.86%
2020280.79M125.62%
2019124.46M-10.37%
2018138.85M-11.34%

IDEAYA Biosciences, Inc. (IDYA) Average Enterprise Value

How has IDYA Enterprise Value performed in the past?

The current Enterprise Value of IDEAYA Biosciences, Inc. (IDYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.11B

5-year avg

746.41M

10-year avg

575.36M

IDEAYA Biosciences, Inc. (IDYA) Enterprise Value vs. Peers

How is IDYA’s Enterprise Value compared to its peers?

IDEAYA Biosciences, Inc.’s Enterprise Value is greater than AnaptysBio, Inc. (251.68M), greater than MeiraGTx Holdings plc (443.72M), greater than Keros Therapeutics, Inc. (169.53M), greater than Homology Medicines, Inc. (-103303255.00), greater than Ventyx Biosciences, Inc. (109.78M), less than Protagonist Therapeutics, Inc. (2.21B), less than Verona Pharma plc (3.46B), greater than Syndax Pharmaceuticals, Inc. (980.05M), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Avidity Biosciences, Inc. (3.35B), less than Revolution Medicines, Inc. (7.93B), greater than Day One Biopharmaceuticals, Inc. (852.53M), less than SpringWorks Therapeutics, Inc. (2.67B), greater than Terns Pharmaceuticals, Inc. (219.57M), greater than Acumen Pharmaceuticals, Inc. (104.95M), greater than Amylyx Pharmaceuticals, Inc. (206.29M), less than MoonLake Immunotherapeutics (2.92B), greater than X4 Pharmaceuticals, Inc. (83.12M), greater than Inozyme Pharma, Inc. (209.16M), greater than VectivBio Holding AG (848.58M),

Build a custom stock screener for IDEAYA Biosciences, Inc. (IDYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDEAYA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IDEAYA Biosciences, Inc. (IDYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IDEAYA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is IDEAYA Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for IDEAYA Biosciences, Inc. (IDYA)?

What is the 3-year average Enterprise Value for IDEAYA Biosciences, Inc. (IDYA)?

What is the 5-year average Enterprise Value for IDEAYA Biosciences, Inc. (IDYA)?

How does the current Enterprise Value for IDEAYA Biosciences, Inc. (IDYA) compare to its historical average?